Treatment with an immature dendritic cell-targeting vaccine supplemented with IFN-α and an inhibitor of DNA methylation markedly enhances survival in a murine melanoma model.
Cancer Immunol Immunother
; 69(4): 569-580, 2020 Apr.
Article
in En
| MEDLINE
| ID: mdl-31980915
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dendritic Cells
/
Melanoma, Experimental
/
Interferon-alpha
/
Cancer Vaccines
/
Decitabine
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
Germany